Humanalbumintherapie und prognostischer Wert der kolloid-osmotischen Druckbestimmung auf der chirurgischen Intensivstation = Traitement par albumine humaine et valeur pronostique de la détermination osmotiquue colloïde dans une unité de soins intensifs chirurgicale = Human albumin therapy and prognostic value of colloid osmotic pressure determination in the surgical intensive care unitGRUNDMANN, R; TUBERGEN, D.Infusionstherapie und klinische Ernährung. 1987, Vol 14, Num 6, pp 284-288, issn 0378-0791Article

CHRONIC MUCOCUTANEOUS CANDIDIASIS CLINICALLY EXACERBATED BY TYPE 1 HYPERSENSITIVITYSIMON MR; TUBERGEN D; CASSIDY J et al.1979; CLIN. IMMUNOL. IMMUNOPATHOL.; USA; DA. 1979; VOL. 14; NO 1; PP. 56-63; BIBL. 31 REF.Article

Stent migration necessitating surgical interventionDILLER, R; SENNINGER, N; KAUTZ, G et al.Surgical endoscopy. 2003, Vol 17, Num 11, pp 1803-1807, issn 0930-2794, 5 p.Article

Long-term survival of children with acute non-lymphoblastic leukemiaODOM, L. F; MORSE, H; TUBERGEN, D. G et al.Medical and pediatric oncology. 1988, Vol 16, Num 4, pp 248-254, issn 0098-1532Article

Prognosis in acute lymphoblastic leukemia of childhood as determined by cytogenetic studies at diagnosis = Le pronostic de la leucémie lymphoblastique aiguë de l'enfant déterminé par les études cytogénétiques au moment du diagnosticMORSE, H. G; ODOM, L. F; TUBERGEN, D et al.Medical and pediatric oncology. 1983, Vol 11, Num 5, pp 310-318, issn 0098-1532Article

Craniospinal irradiation for acute lymphoblastic leukemia with central nervous system disease at diagnosis : A report from the children's cancer groupCHERLOW, J. M; SATHER, H; STEINHERZ, P et al.International journal of radiation oncology, biology, physics. 1996, Vol 36, Num 1, pp 19-27, issn 0360-3016Article

Ultrasonography for thyroid screening after head and neck irradiation in childhood cancer survivorsCROM, D. B; KASTE, S. C; TUBERGEN, D. G et al.Medical and pediatric oncology. 1997, Vol 28, Num 1, pp 15-21, issn 0098-1532Article

CD2 antigen expression on leukemic cells as a predictor of event-free survival after chemotherapy for T-lineage acute lymphoblastic leukemia : A children's cancer group studyUCKUN, F. M; STEINHERZ, P. G; SATHER, H et al.Blood. 1996, Vol 88, Num 11, pp 4288-4295, issn 0006-4971Article

Low numbers of CSF blasts at diagnosis do not predict for the development of CNS leukemia in children with intermediate-risk acute lymphoplastic leukemia : a Childrens Cancer Group reportGILCHRIST, G. S; TUBERGEN, D. G; SATHER, H. N et al.Journal of clinical oncology. 1994, Vol 12, Num 12, pp 2594-2600, issn 0732-183XArticle

Clinical features and treatment outcome of children with myeloid antigen positive acute lymphoblastic leukemia : A report from the Children's Cancer GroupUCKUN, F. M; SATHER, H. N; GAYNON, P. S et al.Blood. 1997, Vol 90, Num 1, pp 28-35, issn 0006-4971Article

Phase I trial and pharmacokinetic (PK) and pharmacodynamics (PD) study of topotecan using a five-day course in children with refractory solid tumors : A Pediatric Oncology Group StudyTUBERGEN, D. G; STEWART, C. F; VIETTI, T. J et al.Journal of pediatric hematology/oncology. 1996, Vol 18, Num 4, pp 352-361, issn 1077-4114Conference Paper

Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features : a Childrens Cancer Group phase III trialTUBERGEN, D. G; GILCHRIST, G. S; O'BRIEN, R. T et al.Journal of clinical oncology. 1993, Vol 11, Num 3, pp 527-537, issn 0732-183XArticle

The effect of methotrexate on the bioavailability of oral 6-mercaptopurineBALIS, F. M; HOLCENBERG, J. S; ZIMM, S et al.Clinical pharmacology and therapeutics. 1987, Vol 41, Num 4, pp 384-387, issn 0009-9236Article

Comparison of treatment regimens for pediatric lymphoblastic non-Hodgkin's lymphoma : a childrens cancer group studyTUBERGEN, D. G; KRAILO, M. D; MEADOWS, A. T et al.Journal of clinical oncology. 1995, Vol 13, Num 6, pp 1368-1376, issn 0732-183XArticle

Blasts in CSF with a normal cell count do not justify alteration of therapy for acute lymphoblastic leukemia in remission : a childrens cancer group studyTUBERGEN, D. G; CULLEN, J. W; BOYETT, J. M et al.Journal of clinical oncology. 1994, Vol 12, Num 2, pp 273-278, issn 0732-183XArticle

Prevention of CNS disease in intermediate-risk acute lymphoblastic leukemia : comparison of cranial radiation and intrathecal methotrexate and the importance of systemic therapy : a Childrens Cancer Group reportTUBERGEN, D. G; GILCHRIST, G. S; O'BRIEN, R. T et al.Journal of clinical oncology. 1993, Vol 11, Num 3, pp 520-526, issn 0732-183XArticle

Early response to therapy and outcome in childhood acute lymphoblastic leukemia a reviewGAYNON, P. S; DESAI, A. A; TUBERGEN, D. G et al.Cancer. 1997, Vol 80, Num 9, pp 1717-1726, issn 0008-543XConference Paper

Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemiaSMITH, M; ARTHUR, D; MURPHY, S et al.Journal of clinical oncology. 1996, Vol 14, Num 1, pp 18-24, issn 0732-183XArticle